Originally published February 18, 2009 at 12:00 AM | Page modified February 18, 2009 at 1:37 PM
Cell Therapeutics stock resumes trading after week-long halt
By Seattle Times business staff
After a week-long suspension, shares of Cell Therapeutics resumed trading Wednesday on Nasdaq and the Borsa Italiana in Milan.
Trading was halted by the Milan exchange Feb. 10 as Italian securities regulators pressed the cash-strapped Seattle biotechnology company for detailed financial information not contained in its U.S. securities filings. Nasdaq stopped U.S. trading in reaction to the Italian move.
Cell Therapeutics said late Tuesday that the Borsa Italiana had confirmed it was lifting the trading halt after the company submitted additional information on its business operations and financial condition.
The company's stock is traded in Italy because it has a large number of stockholders there following its 2003 acquisition of Novuspharma, a Milan-based biotech company. It is now trying to sell its Italian operations.
Before the trading halt, Cell Therapeutics shares last traded at 8 cents, with a 52-week range of $16.70 to 5 cents. The stock closed today at 6.9 cents, down 1.5 cents, or 18 percent, on Nasdaq.
The 16-year-old company has an accumulated deficit of more than $1 billion and in recent months has issued vast quantities of new stock as it restructures its debt.
Copyright © 2009 The Seattle Times Company

Dear Tom and Ray: My wife Olivia's first car (in the early '70s) was a purple-sparkle dune buggy built on a VW Bug frame — one of the least-safe...
Post a comment
- ‘Miracles’: 3 survive I-5 collapse
- McNerney: Boeing will squeeze suppliers and cut jobs
- Percy Harvin already impressing Seahawks teammates, coaches
- Bridge collapse will cause holiday travel headaches
- Span wasn’t built to take critical hit
- Detour route already crowded; avoid it or leave early, officials say
- Trucker bumps I-5 bridge, sees tragedy behind him
- Turmoil surrounds program to help prostitutes
- Jesus Montero's days as Mariners catcher are over
- Sinking Mariners lose sixth straight game; changes ahead?
- Stunning I-5 bridge collapse
208 - Vote on gay Scouts comes at emotional moment
202 - Scouts’ vote on gays met with celebration, sadness
175 - Bridge collapses on Interstate 5 over Skagit River; cars in the water
157 - Mariners option Jesus Montero to AAA, all but ending catching career
157 - Here's what's going on with Robert Andino
96 - Mariners options for rotation help getting thinner by the day
91 - Zimmerman lawyers release Trayvon Martin’s texts about smoking pot, guns
89 - Detour route already crowded; avoid it or leave early, officials say
81 - Some unions now angry about health care overhaul
43
- ‘Miracles’: 3 survive I-5 collapse
- McNerney: Boeing will squeeze suppliers and cut jobs
- More applicants make getting into UW tougher this year
- Bridge collapse will cause holiday travel headaches
- Careers carved at wood-tech center
- Span wasn’t built to take critical hit
- Detour route already crowded; avoid it or leave early, officials say
- Doctors save Ohio boy by ‘printing’ an airway tube | Close-up
- Food-video site launched by Bellevue consumer-research firm
- Council panel OKs zoning for big pot-growing operations







